Alveron Pharma Commences Clinical Trial Of New Intracranial Haemorrhage DrugVicky Coghlan2024-11-28T14:47:31+00:00March 31st, 2023|BioCity Nottingham, News|
Myconeos Innovate UK Smart Grant SuccessVicky Coghlan2023-03-28T14:48:14+01:00March 28th, 2023|BioCity Nottingham, News|
NanoSyrinx Joins Life Sciences Incubator In NottinghamAmy Cotterill2024-11-28T14:47:44+00:00March 27th, 2023|Accelerator, BioCity Nottingham, Investment, News|
Life Sciences Investing: Pioneer Group Reinvests In Biotech Firm NuVisionVicky Coghlan2024-11-28T14:48:12+00:00March 9th, 2023|Accelerator, BioCity Nottingham, Investment, News|
New Platform Set To Accelerate Early-Stage Targeted Protein Degradation ProgrammesVicky Coghlan2024-11-28T14:07:30+00:00March 7th, 2023|Article, BioCity Nottingham, News|
Pioneer Group Announce Lead Investment In Selentus ScienceVicky Coghlan2024-11-28T14:49:26+00:00February 7th, 2023|BioCity Nottingham, Investment, News|
Pioneer Group And Ignite To Welcome 75 Young Women To BioCity Nottingham To Learn About Careers In STEMHannah Andrews2024-11-21T10:41:59+00:00October 1st, 2022|BioCity Nottingham|
Nottingham Marketing Pro Joins V FormationGemma Cann2025-08-11T11:55:58+01:00July 29th, 2022|BioCity Nottingham, News|
Platelet Services Doubles Lab Footprint At BioCity NottinghamGemma Cann2024-11-28T14:50:59+00:00July 4th, 2022|BioCity Nottingham, News|
Upperton Pharma Solutions Announces £15m Investment In New FacilitiesGemma Cann2024-11-28T14:54:01+00:00May 23rd, 2022|BioCity Nottingham, News|
